Active Ingredient: Desloratadine
Desloratadine is indicated in adults, adolescents and children over the age of 1 year for the relief of symptoms associated with:
For this indication, competent medicine agencies globally authorize below treatments:
For:
Oral, 5 milligrams desloratadine, once daily.
The recommended dose of desloratadine is 5 mg once a day.
Intermittent allergic rhinitis (presence of symptoms for less than 4 days per week or for less than 4 weeks) should be managed in accordance with the evaluation of patient's disease history and the treatment could be discontinued after symptoms are resolved and reinitiated upon their reappearance.
In persistent allergic rhinitis (presence of symptoms for 4 days or more per week and for more than 4 weeks), continued treatment may be proposed to the patients during the allergen exposure periods.
The dose can be taken with or without food.
For:
Regimen A, in case that patient age in years is ≥ 1 and patient age in years is ≤ 5
Oral, 1.25 milligrams desloratadine, once daily.
Regimen B, in case that patient age in years is ≥ 6
Oral, 2.5 milligrams desloratadine, once daily.
The prescriber should be aware that most cases of rhinitis below 2 years of age are of infectious origin and there are no data supporting the treatment of infectious rhinitis with desloratadine.
Children 1 through 5 years of age: 1.25 mg once a day.
Children 6 through 11 years of age: 2.5 mg once a day.
The safety and efficacy of desloratadine in children below the age of 1 year have not been established.
There is limited clinical trial efficacy experience with the use of desloratadine in children 1 through 11 years of age and adolescents 12 through 17 years of age.
Intermittent allergic rhinitis (presence of symptoms for less than 4 days per week or for less than 4 weeks) should be managed in accordance with the evaluation of patient's disease history and the treatment could be discontinued after symptoms are resolved and reinitiated upon their reappearance. In persistent allergic rhinitis (presence of symptoms for 4 days or more per week and for more than 4 weeks), continued treatment may be proposed to the patients during the allergen exposure periods.
The dose can be taken with or without food.
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.